EGFR as a potent CAR T target in triple negative breast cancer brain metastases-Reference-Cited by-同舟云学术

EGFR as a potent CAR T target in triple negative breast cancer brain metastases

Published:2022-11-01 Issue:1 Volume:197 Page:57-69
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Subham Siddharth,Jeppson John D.,Worcester Colette,Schatmeyer Bryan,Zhao Jie,Madan Rashna,Lakis Nelli S.,Kimler Bruce F.,McGuirk Joseph P.,Chen Ronald C.,Stecklein Shane R.,Akhavan David^ORCID

Funder

School of Medicine, University of Kansas

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-022-06783-1.pdf

Reference64 articles.

1. Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics, 2022. CA 72:7–33. https://doi.org/10.3322/caac.21708

2. Brosnan EM, Anders CK (2018) Understanding patterns of brain metastasis in breast cancer and designing rational therapeutic strategies. Ann Transl Med 6:163. https://doi.org/10.21037/atm.2018.04.35

3. Schmid P, Adams S, Rugo HS, Schneeweiss A, Barrios CH, Iwata H, Diéras V, Hegg R, Im S-A, Shaw Wright G, Henschel V, Molinero L, Chui SY, Funke R, Husain A, Winer EP, Loi S, Emens LA (2018) Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer. N Engl J Med 379:2108–2121. https://doi.org/10.1056/NEJMoa1809615

4. Garrido-Castro A, Lin N, Polyak K (2019) Insights into molecular classifications of triple-negative breast cancer: improving patient selection for treatment. Cancer Discov 9:176–198. https://doi.org/10.1158/2159-8290.Cd-18-1177

5. Badve SS, Penault-Llorca F, Reis-Filho JS, Deurloo R, Siziopikou KP, D’Arrigo C, Viale G (2021) Determining PD-L1 status in patients with triple-negative breast cancer: lessons learned from IMpassion130. JNCI. https://doi.org/10.1093/jnci/djab121

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Frontiers and challenges of immune cell therapy research in solid tumors;Chinese Science Bulletin;2024-08-20

2. Ononin inhibits triple-negative breast cancer lung metastasis by targeting the EGFR-mediated PI3K/Akt/mTOR pathway;Science China Life Sciences;2024-06-17

3. Machine learning and bioinformatic analyses link the cell surface receptor transcript levels to the drug response of breast cancer cells and drug off-target effects;PLOS ONE;2024-02-02

4. Novel immunotherapies for breast cancer: Focus on 2023 findings;International Immunopharmacology;2024-02

5. Harnessing immunotherapy for brain metastases: insights into tumor–brain microenvironment interactions and emerging treatment modalities;Journal of Hematology & Oncology;2023-12-16